9-35683243-T-TGG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003289.4(TPM2):c.773-4_773-3dupCC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0391 in 1,472,824 control chromosomes in the GnomAD database, including 899 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.079 ( 770 hom., cov: 0)
Exomes 𝑓: 0.035 ( 129 hom. )
Consequence
TPM2
NM_003289.4 splice_region, intron
NM_003289.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.23
Genes affected
TPM2 (HGNC:12011): (tropomyosin 2) This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-35683243-T-TGG is Benign according to our data. Variant chr9-35683243-T-TGG is described in ClinVar as [Likely_benign]. Clinvar id is 94125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM2 | NM_003289.4 | c.773-4_773-3dupCC | splice_region_variant, intron_variant | ENST00000645482.3 | NP_003280.2 | |||
TPM2 | NM_001301226.2 | c.772+1001_772+1002dupCC | intron_variant | NP_001288155.1 | ||||
TPM2 | NM_001301227.2 | c.773-4_773-3dupCC | splice_region_variant, intron_variant | NP_001288156.1 | ||||
TPM2 | NM_213674.1 | c.772+1001_772+1002dupCC | intron_variant | NP_998839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM2 | ENST00000645482.3 | c.773-4_773-3dupCC | splice_region_variant, intron_variant | NM_003289.4 | ENSP00000496494.2 |
Frequencies
GnomAD3 genomes AF: 0.0788 AC: 11831AN: 150148Hom.: 769 Cov.: 0
GnomAD3 genomes
AF:
AC:
11831
AN:
150148
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0322 AC: 4958AN: 154034Hom.: 1 AF XY: 0.0298 AC XY: 2418AN XY: 81146
GnomAD3 exomes
AF:
AC:
4958
AN:
154034
Hom.:
AF XY:
AC XY:
2418
AN XY:
81146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0345 AC: 45675AN: 1322558Hom.: 129 Cov.: 34 AF XY: 0.0339 AC XY: 22169AN XY: 654466
GnomAD4 exome
AF:
AC:
45675
AN:
1322558
Hom.:
Cov.:
34
AF XY:
AC XY:
22169
AN XY:
654466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0788 AC: 11848AN: 150266Hom.: 770 Cov.: 0 AF XY: 0.0764 AC XY: 5606AN XY: 73416
GnomAD4 genome
AF:
AC:
11848
AN:
150266
Hom.:
Cov.:
0
AF XY:
AC XY:
5606
AN XY:
73416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Eurofins Ntd Llc (ga) | Jul 24, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Arthrogryposis, distal, type 1A;C0546264:Congenital myopathy with fiber type disproportion;C1836447:Congenital myopathy 23 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 28, 2022 | - - |
Arthrogryposis, distal, type 1A Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at